Imegen

About:

Instituto de Medicina Genomica is a biomedical company specialized in services and products for genetic analysis.

Website: http://www.imegen.es/

Twitter/X: imegentw

Top Investors: Fides Capital, Realiza Business Angels

Description:

Instituto de Medicina Genomica (Imegen) is a biomedical company specialized in services and products for genetic analysis. The company’s mission is to improve the health and quality of life of people by means of diagnostic, prognostic, and preventive genetic services. Its aim is to be a worldwide reference in human genetics providing one of the broadest portfolios in genetic analysis. It encourages partnerships with national and international companies and research teams, and continuously invests in R&D to strengthen its competitiveness. Instituto de Medicina Genomica was founded in January 2009 and is based in Paterna, Spain.

Total Funding Amount:

600000 EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Paterna, Comunidad Valenciana, Spain

Founded Date:

2009-07-08

Contact Email:

info(AT)imegen.es

Founders:

Manuel Perez

Number of Employees:

51-100

Last Funding Date:

2017-03-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai